* STRATA Skin Sciences Inc SSKN.OQ SSKN.O is expected
to show
a rise in quarterly revenue when it reports results on March
21.
* The Horsham Pennsylvania-based company is expected to
report a
33.6% increase in revenue to $8.973 million from $6.72 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for STRATA Skin
Sciences Inc
is for a loss of 2 cents per share. For the same quarter last
year, the company reported a loss of 1 cent per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for STRATA Skin
Sciences Inc is $4.3, above its last closing price of $1.52.
This summary was machine generated March 18 at 20:45 GMT. All
figures in US dollars unless otherwise stated